A citation-based method for searching scientific literature

Jian Yang, Pedro A Jose, Chunyu Zeng. J Am Heart Assoc 2017
Times Cited: 19







List of co-cited articles
140 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men.
Jeppe Skov, Anders Dejgaard, Jørgen Frøkiær, Jens Juul Holst, Thomas Jonassen, Søren Rittig, Jens Sandahl Christiansen. J Clin Endocrinol Metab 2013
114
42

Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men.
Jean-Pierre Gutzwiller, Stefan Tschopp, Andreas Bock, Carlos E Zehnder, Andreas R Huber, Monika Kreyenbuehl, Heike Gutmann, Jürgen Drewe, Christoph Henzen, Burkhard Goeke,[...]. J Clin Endocrinol Metab 2004
275
36

Gastrin and D1 dopamine receptor interact to induce natriuresis and diuresis.
Yue Chen, Laureano D Asico, Shuo Zheng, Van Anthony M Villar, Duofen He, Lin Zhou, Chunyu Zeng, Pedro A Jose. Hypertension 2013
42
36

Gastrorenal Axis.
Pedro A Jose, Robin A Felder, Zhiwei Yang, Chunyu Zeng, Gilbert M Eisner. Hypertension 2016
12
50

The physiological role of glucagon-like peptide-1 in the regulation of renal function.
Lívia X S Farah, Vanessa Valentini, Thaissa D Pessoa, Gerhard Malnic, Alicia A McDonough, Adriana C C Girardi. Am J Physiol Renal Physiol 2016
53
26

Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1.
Renato O Crajoinas, Felipe T Oricchio, Thaissa D Pessoa, Bruna P M Pacheco, Lucília M A Lessa, Gerhard Malnic, Adriana C C Girardi. Am J Physiol Renal Physiol 2011
150
26

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
26

Renal effects of glucagon-like peptide in rats.
Carol Moreno, Mahesh Mistry, Richard J Roman. Eur J Pharmacol 2002
80
26

The gut as a sensory organ.
John B Furness, Leni R Rivera, Hyun-Jung Cho, David M Bravo, Brid Callaghan. Nat Rev Gastroenterol Hepatol 2013
225
26

GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes.
Marcel H A Muskiet, Lennart Tonneijck, Mark M Smits, Michaël J B van Baar, Mark H H Kramer, Ewout J Hoorn, Jaap A Joles, Daniël H van Raalte. Nat Rev Nephrol 2017
134
26

Gastrin decreases Na+,K+-ATPase activity via a PI 3-kinase- and PKC-dependent pathway in human renal proximal tubule cells.
Tianbing Liu, Prasad R Konkalmatt, Yu Yang, Pedro A Jose. Am J Physiol Endocrinol Metab 2016
19
26

The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?
Marcel H A Muskiet, Mark M Smits, Linde M Morsink, Michaela Diamant. Nat Rev Nephrol 2014
117
21

Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis.
Feng Sun, Shanshan Wu, Jing Wang, Shuxia Guo, Sanbao Chai, Zhirong Yang, Lishi Li, Yuan Zhang, Linong Ji, Siyan Zhan. Clin Ther 2015
100
21

Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial.
Lennart Tonneijck, Mark M Smits, Marcel H A Muskiet, Trynke Hoekstra, Mark H H Kramer, A H Jan Danser, Michaela Diamant, Jaap A Joles, Daniël H van Raalte. Diabetologia 2016
61
21

Renal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy men.
Ali Asmar, Lene Simonsen, Meena Asmar, Sten Madsbad, Jens J Holst, Erik Frandsen, Cedric Moro, Thomas Jonassen, Jens Bülow. Am J Physiol Endocrinol Metab 2015
48
21

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
21

GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.
Charles Pyke, R Scott Heller, Rikke K Kirk, Cathrine Ørskov, Steffen Reedtz-Runge, Peter Kaastrup, Anders Hvelplund, Linda Bardram, Dan Calatayud, Lotte Bjerre Knudsen. Endocrinology 2014
401
21


Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow.
Elisa P Jensen, Steen S Poulsen, Hannelouise Kissow, Niels-Henrik Holstein-Rathlou, Carolyn F Deacon, Boye L Jensen, Jens J Holst, Charlotte M Sorensen. Am J Physiol Renal Physiol 2015
68
21

Sodium challenge does not support an acute gastrointestinal-renal natriuretic signaling axis in humans.
Richard A Preston, David Afshartous, Leonard R Forte, Rolando Rodco, Alberto B Alonso, Dyal Garg, Leopoldo Raij. Kidney Int 2012
17
23

The Synergistic Roles of Cholecystokinin B and Dopamine D5 Receptors on the Regulation of Renal Sodium Excretion.
Xiaoliang Jiang, Wei Chen, Xing Liu, Zihao Wang, Yunpeng Liu, Robin A Felder, John J Gildea, Pedro A Jose, Chuan Qin, Zhiwei Yang. PLoS One 2016
17
23


Gastrin stimulates renal dopamine production by increasing the renal tubular uptake of l-DOPA.
Xiaoliang Jiang, Yanrong Zhang, Yu Yang, Jian Yang, Laureano D Asico, Wei Chen, Robin A Felder, Ines Armando, Pedro A Jose, Zhiwei Yang. Am J Physiol Endocrinol Metab 2017
6
66

Gut-kidney kaliuretic signaling: looking forward to feeding.
Ewout J Hoorn, Robert Zietse. Kidney Int 2015
9
33

Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes.
Julie A Lovshin, Annette Barnie, Ariana DeAlmeida, Alexander Logan, Bernard Zinman, Daniel J Drucker. Diabetes Care 2015
102
15

The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential.
Hiroki Fujita, Tsukasa Morii, Hiromi Fujishima, Takehiro Sato, Tatsunori Shimizu, Mihoko Hosoba, Katsushi Tsukiyama, Takuma Narita, Takamune Takahashi, Daniel J Drucker,[...]. Kidney Int 2014
171
15

Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes.
Bernt Johan von Scholten, Tine Willum Hansen, Jens Peter Goetze, Frederik Persson, Peter Rossing. J Diabetes Complications 2015
38
15

Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells.
P Schlatter, C Beglinger, J Drewe, H Gutmann. Regul Pept 2007
102
15

Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial.
J Skov, M Pedersen, J J Holst, B Madsen, J P Goetze, S Rittig, T Jonassen, J Frøkiaer, A Dejgaard, J S Christiansen. Diabetes Obes Metab 2016
67
15

Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment.
B J von Scholten, M Lajer, J P Goetze, F Persson, P Rossing. Diabet Med 2015
48
15

Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.
Abd A Tahrani, Anthony H Barnett, Clifford J Bailey. Nat Rev Endocrinol 2016
158
15

Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men.
M H A Muskiet, L Tonneijck, M M Smits, M H H Kramer, M Diamant, J A Joles, D H van Raalte. Diabetes Obes Metab 2016
46
15


Pleiotropic effects of type 2 diabetes management strategies on renal risk factors.
Marcel H A Muskiet, Lennart Tonneijck, Mark M Smits, Mark H H Kramer, Hiddo J Lambers Heerspink, Daniël H van Raalte. Lancet Diabetes Endocrinol 2015
52
15


Glucagon-like peptide-1 receptor stimulation increases GFR and suppresses proximal reabsorption in the rat.
Scott C Thomson, Ali Kashkouli, Prabhleen Singh. Am J Physiol Renal Physiol 2013
49
15

Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and urea.
Lise Bankir, Ronan Roussel, Nadine Bouby. Am J Physiol Renal Physiol 2015
60
15

GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure.
Minsuk Kim, Mathew J Platt, Tadao Shibasaki, Susan E Quaggin, Peter H Backx, Susumu Seino, Jeremy A Simpson, Daniel J Drucker. Nat Med 2013
300
15

Control of renal solute excretion by enteric signals and mediators.
Leslie Thomas, Rajiv Kumar. J Am Soc Nephrol 2008
10
30


A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
Xavier Pi-Sunyer, Arne Astrup, Ken Fujioka, Frank Greenway, Alfredo Halpern, Michel Krempf, David C W Lau, Carel W le Roux, Rafael Violante Ortiz, Christine Bjørn Jensen,[...]. N Engl J Med 2015
744
15

Glucagon-like peptide-1 does not have acute effects on central or renal hemodynamics in patients with type 2 diabetes without nephropathy.
Ali Asmar, Lene Simonsen, Meena Asmar, Sten Madsbad, Jens J Holst, Erik Frandsen, Cedric Moro, Charlotte M Sorensen, Thomas Jonassen, Jens Bülow. Am J Physiol Endocrinol Metab 2016
21
15


Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses.
M A Nauck, E Homberger, E G Siegel, R C Allen, R P Eaton, R Ebert, W Creutzfeldt. J Clin Endocrinol Metab 1986
576
15

Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
M Tang-Christensen, P J Larsen, R Göke, A Fink-Jensen, D S Jessop, M Møller, S P Sheikh. Am J Physiol 1996
448
15

Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis.
Feng Sun, Shanshan Wu, Shuxia Guo, Kai Yu, Zhirong Yang, Lishi Li, Yuan Zhang, Xiaochi Quan, Linong Ji, Siyan Zhan. Diabetes Res Clin Pract 2015
145
15

Regulation of Na+/H+ exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells.
Luciene R Carraro-Lacroix, Gerhard Malnic, Adriana C C Girardi. Am J Physiol Renal Physiol 2009
92
15

Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition.
Mathijs C Bunck, Michaela Diamant, Bjorn Eliasson, Anja Cornér, Rimma M Shaginian, Robert J Heine, Marja-Riitta Taskinen, Hannele Yki-Järvinen, Ulf Smith. Diabetes Care 2010
104
15

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.
Rury R Holman, M Angelyn Bethel, Robert J Mentz, Vivian P Thompson, Yuliya Lokhnygina, John B Buse, Juliana C Chan, Jasmine Choi, Stephanie M Gustavson, Nayyar Iqbal,[...]. N Engl J Med 2017
829
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.